{"id":4317,"date":"2024-05-28T16:26:57","date_gmt":"2024-05-28T13:26:57","guid":{"rendered":"https:\/\/staging.iasispharma.com\/en\/?p=4317"},"modified":"2026-10-30T13:29:44","modified_gmt":"2026-10-30T11:29:44","slug":"iasis-pharma-participation-at-the-3rd-innovationasygros-congress","status":"publish","type":"post","link":"https:\/\/iasispharma.com\/en\/all-articles\/iasis-pharma-participation-at-the-3rd-innovationasygros-congress\/","title":{"rendered":"IASIS PHARMA PARTICIPATION at the 3rd Innovation@ASygros Congress"},"content":{"rendered":"<p><strong>0<\/strong><strong>5<\/strong><strong>\/<\/strong><strong>23<\/strong><strong>-2<\/strong><strong>5<\/strong><strong>\/2024.<\/strong><\/p>\n<p><strong>Athens Concert Hall, Hellas<\/strong><\/p>\n<p><strong>IASIS PHARMA<\/strong> participated in the <strong>3rd Innovation@ASygros Congress<\/strong> held on May 23 &#8211; 25, 2024 at the Concert Hall in Athens.<\/p>\n<p>The conference was organized by the First University Clinic of Venereal and Skin Diseases of the Andreas Sygros Hospital.<\/p>\n<p>Greek Dermatologists attended the congress and had the chance to visit\u00a0<strong>IASIS PHARMA<\/strong>\u00a0exhibition stand and got informed of 3 important IASIS Dermatological products:<\/p>\n<ul>\n<li><strong>Isotroin<sup>\u00ae<\/sup><\/strong>\/ Isotretinoin (at the <strong>new &amp; unique<\/strong> <strong>30mg<\/strong> dosage) indicated for Severe forms of Acne that are resistant to treatment with systemically administered antibiotics and topical therapy. <strong>Isotroin<\/strong>\u00ae<strong> 30mg<\/strong> \u00a0is added to the range of the other Isotroin\u00ae strengths \u00a0(10mg, 20mg &amp; 40mg).<\/li>\n<li><strong>Combi<sup>\u00ae<\/sup><\/strong>, a combination of fluprednidene (1mg) + miconazole (20mg) cream for the treatment of Inflammatory Dermatomycoses.<\/li>\n<li><strong>Modiwart<sup>\u00ae<\/sup><\/strong>\/\u0399miquimod (12,5mg\/sachet), an innovative modifier of the immune response system indicated for the treatment of: External Genital Warts, Superficial Basal Cell Carcinomas and Aktinic Keratoses.<\/li>\n<\/ul>\n<p><img decoding=\"async\" class=\"alignleft wp-image-4308\" src=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2024\/05\/3o-innovation-sygros-photo-copy.png\" alt=\"3o-innovation-sygros-stand\" width=\"513\" height=\"620\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>05\/23-25\/2024. Athens Concert Hall, Hellas IASIS PHARMA participated in the 3rd Innovation@ASygros Congress held on May 23 &#8211; 25, 2024 at the Concert Hall in Athens. The conference was organized by the First University Clinic of Venereal and Skin Diseases of the Andreas Sygros Hospital. Greek Dermatologists attended the congress and had the chance to  [&#8230;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":true,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[33,157,204],"tags":[],"class_list":["post-4317","post","type-post","status-publish","format-standard","hentry","category-all-articles","category-press-room-en","category-conferences"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7HJeP-17D","jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/4317","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/comments?post=4317"}],"version-history":[{"count":3,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/4317\/revisions"}],"predecessor-version":[{"id":4320,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/4317\/revisions\/4320"}],"wp:attachment":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/media?parent=4317"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/categories?post=4317"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/tags?post=4317"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}